CIK: 1808356 - Address: C/O Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco, CA 94158
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/20/24 21:12
5/17/24
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-111.750-6-3230D
2/22/24 20:17
2/20/24
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-50.68000-8-3237D
11/20/23 21:00
11/17/23
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-40.49000-7-3244D
8/17/23 20:07
8/16/23
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-60.78000-7-3251D
5/17/23 20:28
5/16/23
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-50.72000-8-3258D
2/17/23 20:59
2/16/23
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-253.000-8-3265D
11/18/22 18:04
11/16/22
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOGCS-313.570-9-3272D
8/17/22 19:40
8/16/22
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS.d-154.760-3-1281D
5/17/22 21:38
5/16/22
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-123.950-3-3118D
2/18/22 18:18
2/16/22
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-4010.950-4-3121D
11/17/21 18:09
11/16/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-8613.160-7-786D
8/18/21 19:02
8/16/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-2613.830-2-373D
5/19/21 19:07
5/17/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-3518.300-2-275D
2/18/21 19:06
2/16/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-4922.370-2-377D
2/4/21 20:44
2/3/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCM.d478.8005779D
2/4/21 20:44
2/3/21
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS.d-10419.450-5-679D
11/18/20 19:07
11/16/20
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-2616.930-2-350D
8/19/20 18:40
8/17/20
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-3019.670-2-351D
5/20/20 18:32
5/18/20
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsWilson Mark AndrewCAOSVP,GCS-3422.510-2-352D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact